Table of Contents
ISRN Genetics
Volume 2013, Article ID 961293, 10 pages
http://dx.doi.org/10.5402/2013/961293
Review Article

Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis

Molecular & Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow 226007, India

Received 30 May 2012; Accepted 31 July 2012

Academic Editors: C. Walss-Bass, A. Yamamoto, and A. Zamborlini

Copyright © 2013 Monisha Banerjee and Deepika Misra. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Alcántara, R. García-Cavazos, E. Hernández-U, A. González-Del Angel, A. Carnevale, and L. Orozco, “Carrier detection and prenatal molecular diagnosis in a duchenne muscular dystrophy family without any affected relative available,” Annales de Genetique, vol. 44, no. 3, pp. 149–153, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. W. Steele and W. R. Breg, “Chromosome analysis of human amniotic-fluid cells,” The Lancet, vol. 1, no. 7434, pp. 383–385, 1966. View at Google Scholar · View at Scopus
  3. Thompson, and Thompson, Genetics in Medicine, WB Saunders, Philadelphia, Pa, USA, 7th edition, 2007.
  4. M. Mukherjee, G. S. Pandey, A. Kesari, S. R. Phadke, and B. Mittal, “Prenatal diagnosis of genetic disorders by molecular methods,” Perinatology, vol. 6, no. 5, pp. 221–230, 2004. View at Google Scholar · View at Scopus
  5. P. Mandel and P. Metais, “Les acides nucleiques du plasma sanguine chez I'homme,” Comptes Rendus de l'Académie des Sciences, vol. 142, pp. 241–243, 1948. View at Google Scholar
  6. A. R. Thierry, F. Mouliere, C. Gongora et al., “Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts,” Nucleic Acids Research, vol. 38, no. 18, Article ID gkq421, pp. 6159–6175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Urbanova, J. Plzak, H. Strnad, and J. Betka, “Circulating nucleic acids as a new diagnostic tool,” Cellular and Molecular Biology Letters, vol. 15, no. 2, pp. 242–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Leon, B. Shapiro, D. M. Sklaroff, and M. J. Yaros, “Free DNA in the serum of cancer patients and the effect of therapy,” Cancer Research, vol. 37, no. 3, pp. 646–650, 1977. View at Google Scholar · View at Scopus
  9. Y. M. D. Lo, M. S. C. Tein, T. K. Lau et al., “Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis,” American Journal of Human Genetics, vol. 62, no. 4, pp. 768–775, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. C. F. Wright and H. Burton, “The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis,” Human Reproduction Update, vol. 15, no. 1, pp. 139–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Cetin, “Cell-free fetal DNA and RNA circulating in maternal blood: review, part I,” Basic and Clinical Sciences, vol. 52, no. 3, pp. 52–60, 2010. View at Google Scholar
  12. D. W. Bianchi, “Circulating fetal DNA: its origin and diagnostic potential—a review,” Placenta, vol. 25, pp. S93–S101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Bianchi, J. M. Williams, L. M. Sullivan, F. W. Hanson, K. W. Klinger, and A. P. Shuber, “PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies,” American Journal of Human Genetics, vol. 61, no. 4, pp. 822–829, 1997. View at Google Scholar · View at Scopus
  14. V. Swarup and M. R. Rajeswari, “Circulating (cell-free) nucleic acids—a promising, non-invasive tool for early detection of several human diseases,” FEBS Letters, vol. 581, no. 5, pp. 795–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. L. M. Poon, T. N. Leung, T. K. Lau, and Y. M. D. Lo, “Presence of fetal RNA in maternal plasma,” Clinical Chemistry, vol. 46, no. 11, pp. 1832–1834, 2000. View at Google Scholar · View at Scopus
  16. N. D. Avent, T. E. Madgett, D. G. Maddocks, and P. W. Soothill, “Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications,” Current Opinion in Obstetrics and Gynecology, vol. 21, no. 2, pp. 175–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. R. W. Chiu, R. Akolekar, Y. W. Zheng et al., “Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study,” British Medical Journal, vol. 342, article c7401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. K. O. Ng, N. B. Y. Tsui, T. K. Lau et al., “mRNA of placental origin is readily detectable in maternal plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 8, pp. 4748–4753, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. N. B. Y. Tsui, S. S. C. Chim, R. W. K. Chiu et al., “Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling,” Journal of Medical Genetics, vol. 41, no. 6, pp. 461–467, 2004. View at Google Scholar · View at Scopus
  20. A. K. Gupta, W. Holzgreve, B. Huppertz, A. Malek, H. Schneider, and S. Hahn, “Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro,” Clinical Chemistry, vol. 50, no. 11, pp. 2187–2190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Maron, K. L. Johnson, D. Slonim et al., “Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood,” Journal of Clinical Investigation, vol. 117, no. 10, pp. 3007–3019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. M. D. Lo and R. W. K. Chiu, “Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis,” Clinical Chemistry, vol. 54, no. 3, pp. 461–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Nelson, C. Eagle, M. Langshaw, H. Popp, and H. Kronenberg, “Genotyping fetal DNA by non-invasive means: extraction from maternal plasma,” Vox Sanguinis, vol. 80, no. 2, pp. 112–116, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Gozdziewicz, K. Gruca-Stryjak, P. Wirstlein, J. Kornacki, and J. Skrzypczak, “Free fetal DNA maternal plasma concentration as predictive factor of hypertensive disorders in pregnancy,” Archives of Perinatal Medicine, vol. 15, pp. 17–20, 2009. View at Google Scholar
  25. A. Sekizawa, Y. Purwosunu, R. Matsuoka et al., “Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood,” Journal of Obstetrics and Gynaecology Research, vol. 33, no. 6, pp. 747–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Farina, E. Caramelli, M. Concu et al., “Testing normality of fetal DNA concentration in maternal plasma at 10-12 completed weeks' gestation: a preliminary approach to a new marker for genetic screening,” Prenatal Diagnosis, vol. 22, no. 2, pp. 148–152, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. C. Chan, R. W. K. Chiu, and Y. M. D. Lo, “Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis,” Annals of Clinical Biochemistry, vol. 40, no. 2, pp. 122–130, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Li, B. Zimmermann, C. Rusterholz, A. Kang, W. Holzgreve, and S. Hahn, “Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms,” Clinical Chemistry, vol. 50, no. 6, pp. 1002–1011, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. A. Chan, J. Zhang, A. B. Y. Hui et al., “Size distributions of maternal and fetal DNA in maternal plasma,” Clinical Chemistry, vol. 50, no. 1, pp. 88–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Vecchione, M. Tomaiuolo, M. Sarno et al., “Fetal sex identification in maternal plasma by means of short tandem repeats on chromosome X,” Annals of the New York Academy of Sciences, vol. 1137, pp. 148–156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Li, E. Di Naro, A. Vitucci, B. Zimmermann, W. Holzgreve, and S. Hahn, “Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma,” The Journal of the American Medical Association, vol. 293, no. 7, pp. 843–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. F. M. F. Lun, R. W. K. Chiu, K. C. A. Chan, T. Y. Leung, T. K. Lau, and Y. M. D. Lo, “Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma,” Clinical Chemistry, vol. 54, no. 10, pp. 1664–1672, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. R. J. P. Rijnders, R. B. van der Luijt, E. D. J. Peters et al., “Earliest gestational age for fetal sexing in cell-free maternal plasma,” Prenatal Diagnosis, vol. 23, no. 13, pp. 1042–1044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Saito, A. Sekizawa, T. Morimoto, M. Suzuki, and T. Yanaihara, “Prenatal DNA diagnosis of a single-gene disorder from maternal plasma,” The Lancet, vol. 356, no. 9236, p. 1170, 2000. View at Google Scholar · View at Scopus
  35. R. W. K. Chiu, T. K. Lau, T. N. Leung, K. C. K. Chow, D. H. K. Chui, and Y. M. D. Lo, “Prenatal exclusion of β thalassaemia major by examination of maternal plasma,” The Lancet, vol. 360, no. 9338, pp. 998–1000, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. K. C. K. Chow, R. W. K. Chiu, N. B. Y. Tsui et al., “Mass spectrometric detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma,” Clinical Chemistry, vol. 53, no. 1, pp. 141–142, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. M. D. Lo, N. B. Y. Tsui, R. W. K. Chiu et al., “Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection,” Nature Medicine, vol. 13, no. 2, pp. 218–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. S. C. Chim, Y. K. Tong, R. W. K. Chiu et al., “Detection of the placental epigenetic signature of the maspin gene in maternal plasma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 41, pp. 14753–14758, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. K. Tong, C. Ding, R. W. K. Chiu et al., “Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations,” Clinical Chemistry, vol. 52, no. 12, pp. 2194–2202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. K. C. A. Chan, C. Ding, A. Gerovassili et al., “Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis,” Clinical Chemistry, vol. 52, no. 12, pp. 2211–2218, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Finning, P. Martin, J. Summers, E. Massey, G. Poole, and G. Daniels, “Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study,” British Medical Journal, vol. 336, no. 7648, pp. 816–818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. I. C. Kavanagh and S. C. Baker, “Advances in nucleic acid detection and quantification,” Biochemical Society Transactions, vol. 37, no. 2, pp. e1–e4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Gueudin, J. C. Plantier, F. Damond, P. Roques, P. Mauclère, and F. Simon, “Plasma viral RNA assay in HIV-1 group O infection by real-time PCR,” Journal of Virological Methods, vol. 113, no. 1, pp. 43–49, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. E. S. Morozkin, P. P. Laktionov, E. Y. Rykova, and V. V. Vlassov, “Fluorometric quantification of RNA and DNA in solutions containing both nucleic acids,” Analytical Biochemistry, vol. 322, no. 1, pp. 48–50, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. D. W. Bianchi, “Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy,” Journal of Pediatric Surgery, vol. 42, no. 1, pp. 12–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. L. L. M. Poon, T. N. Leung, T. K. Lau, K. C. K. Chow, and Y. M. D. Lo, “Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma,” Clinical Chemistry, vol. 48, no. 1, pp. 35–41, 2002. View at Google Scholar · View at Scopus
  47. C. Proudhon and D. Bourc'his, “Identification and resolution of artifacts in the interpretation of imprinted gene expression,” Briefings in Functional Genomics, vol. 9, no. 5-6, pp. 374–384, 2010. View at Google Scholar · View at Scopus
  48. Y. M. D. Lo, N. Corbetta, P. F. Chamberlain et al., “Presence of fetal DNA in maternal plasma and serum,” The Lancet, vol. 350, no. 9076, pp. 485–487, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. F. Z. Bischoff, D. E. Lewis, and J. L. Simpson, “Cell-free fetal DNA in maternal blood: kinetics, source and structure,” Human Reproduction Update, vol. 11, no. 1, pp. 59–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Akolekar, D. H. Farkas, A. L. V. Agtmael, A. T. Bombard, and K. H. Nicolaides, “Fetal sex determination using circulating cell-free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation,” Prenatal Diagnosis, vol. 30, no. 10, pp. 918–923, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Illanes, S. A. Fattah, and P. Soothill, “Review non-invasive prenatal diagnosis,” Obstetrics and Gynecology, vol. 8, no. 2, pp. 91–95, 2006. View at Publisher · View at Google Scholar
  52. P. Amicucci, M. Gennarelli, G. Novelli, and B. Dallapiccola, “Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma,” Clinical Chemistry, vol. 46, no. 2, pp. 301–302, 2000. View at Google Scholar · View at Scopus
  53. C. P. Chen, S. R. Chern, and W. Wang, “Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy,” Prenatal Diagnosis, vol. 20, no. 4, pp. 355–357, 2000. View at Google Scholar · View at Scopus
  54. C. P. Chen, S. R. Chern, and W. Wang, “Fetal DNA analyzed in plasma from a mother's three consecutive pregnancies to detect paternally inherited aneuploidy,” Clinical Chemistry, vol. 47, no. 5, pp. 937–939, 2001. View at Google Scholar · View at Scopus
  55. O. G. Holtzman, C. A. Grotegut, J. P. Gaughan, E. J. Holtzman, C. Floro, and E. Hernandez, “Noninvasive fetal RhCE genotyping from maternal blood,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 116, no. 2, pp. 144–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. P. A. Jones and S. B. Baylin, “The epigenomics of cancer,” Cell, vol. 128, no. 4, pp. 683–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Hahn, C. Rusterholz, I. Hösli, and O. Lapaire, “Cell-free nucleic acids as potential markers for preeclampsia,” Placenta, vol. 32, supplement 1, pp. S17–S20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. C. H. Park, H. S. Kim, S. G. Lee, and C. K. Lee, “Methylation status of differentially methylated regions at Igf2/H19 locus in porcine gametes and preimplantation embryos,” Genomics, vol. 93, no. 2, pp. 179–186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. Y.-K. Tong and Y. M. D. Lo, “Diagnostic developments involving cell-free (circulating) nucleic acids,” Clinica Chimica Acta, vol. 363, no. 1-2, pp. 187–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Pfeifer, “Mechanisms of genomic imprinting,” American Journal of Human Genetics, vol. 67, no. 4, pp. 777–787, 2000. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Chappell and L. Morgan, “Searching for genetic clues to the causes of pre-eclampsia,” Clinical Science, vol. 110, no. 4, pp. 443–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Crespi, “Genomic imprinting in the development and evolution of psychotic spectrum conditions,” Biological Reviews, vol. 83, no. 4, pp. 441–493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. Z. Alfirevic, K. Sundberg, and S. Brigham, “Amniocentesis and chorionic villus sampling for prenatal diagnosis,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD003252, 2003. View at Google Scholar · View at Scopus
  64. S. S. C. Chim, S. Jin, T. Y. H. Lee et al., “Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21,” Clinical Chemistry, vol. 54, no. 3, pp. 500–511, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. R. W. Old, F. Crea, W. Puszyk, and M. A. Hultén, “Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome,” Reproductive BioMedicine Online, vol. 15, no. 2, pp. 227–235, 2007. View at Google Scholar · View at Scopus
  66. R. W. K. Chiu, S. S. C. Chim, I. H. N. Wong et al., “Hypermethylation of RASSF1A in human and rhesus placentas,” American Journal of Pathology, vol. 170, no. 3, pp. 941–950, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. R. W. K. Chiu, L. L. M. Poon, T. K. Lau, T. N. Leung, E. M. C. Wong, and Y. M. D. Lo, “Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma,” Clinical Chemistry, vol. 47, no. 9, pp. 1607–1613, 2001. View at Google Scholar · View at Scopus
  68. P. W. Laird, “Principles and challenges of genome-wide DNA methylation analysis,” Nature Reviews Genetics, vol. 11, no. 3, pp. 191–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. K. Tong, R. W. K. Chiu, T. Y. Leung et al., “Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma,” Clinical Chemistry, vol. 53, no. 11, pp. 1906–1914, 2007. View at Publisher · View at Google Scholar · View at Scopus
  70. E. K. O. Ng, N. B. Y. Tsui, N. Y. L. Lam et al., “Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals,” Clinical Chemistry, vol. 48, no. 8, pp. 1212–1217, 2002. View at Google Scholar · View at Scopus
  71. N. B. Y. Tsui, E. K. O. Ng, and Y. M. D. Lo, “Stability of endogenous and added RNA in blood specimens, serum, and plasma,” Clinical Chemistry, vol. 48, no. 10, pp. 1647–1653, 2002. View at Google Scholar · View at Scopus
  72. I. Banzola, C. Rusterholz, L. Zannoni et al., “PLAC4 and β-HCG mRNA levels are not altered in the maternal circulation of pregnancies with trisomy 21,” Prenatal Diagnosis, vol. 28, no. 13, pp. 1262–1267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. J. M. Costa, A. Benachi, and E. Gautier, “New strategy for prenatal diagnosis of X-linked disorders,” The New England Journal of Medicine, vol. 346, no. 19, article 1502, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Z. A. Badawy, A. Etman, V. Cuenca, A. Montante, and L. Kaufman, “Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia,” Obstetrics and Gynecology, vol. 98, no. 3, pp. 374–378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. C. Ding, R. W. K. Chiu, T. K. Lau et al., “MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 29, pp. 10762–10767, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Grunau, S. J. Clark, and A. Rosenthal, “Bisulfite genomic sequencing: systematic investigation of critical experimental parameters,” Nucleic Acids Research, vol. 29, no. 13, article E65, 2001. View at Google Scholar · View at Scopus
  77. V. Bansal, S. Suresh, I. Suresh, S. Jagadeesh, and G. Fazal, “Genetic counseling in chromosomal abnormalities,” Journal of Prenatal Diagnosis and Therapy, vol. 1, no. 1, pp. 14–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. C. Rösch, V. Steinbicker, and S. Kropf, “Down's syndrome: the effects of prenatal diagnosis and demographic factors in a region of the Eastern part of Germany,” European Journal of Epidemiology, vol. 16, no. 7, pp. 627–632, 2000. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Reynolds, “The triple test as a screening technique for Down syndrome: reliability and relevance,” International Journal of Women's Health, vol. 2, no. 1, pp. 83–88, 2010. View at Google Scholar · View at Scopus
  80. T. Wataganara, E. S. LeShane, A. Farina et al., “Maternal serum cell-free fetal DNA levels are increased in cases of trisomy 13 but not trisomy 18,” Human Genetics, vol. 112, no. 2, pp. 204–208, 2003. View at Google Scholar · View at Scopus
  81. C. W. Redman and I. L. Sargent, “Latest advances in understanding preeclampsia,” Science, vol. 308, no. 5728, pp. 1592–1594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Sibai, G. Dekker, and M. Kupferminc, “Pre-eclampsia,” The Lancet, vol. 365, no. 9461, pp. 785–799, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. E. B. Ndayambagye, M. Nakalembe, and D. K. Kaye, “Factors associated with persistent hypertension after puerperium among women with pre-eclampsia/eclampsia in Mulago hospital, Uganda,” BMC Pregnancy and Childbirth, vol. 10, article 12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. W. P. Robinson, M. S. Peñaherrera, R. Jiang et al., “Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction,” Prenatal Diagnosis, vol. 30, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. M. D. Lo, T. N. Leung, M. S. C. Tein et al., “Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia,” Clinical Chemistry, vol. 45, no. 2, pp. 184–188, 1999. View at Google Scholar · View at Scopus
  86. S. Sifakis, A. Zaravinos, N. Maiz, D. A. Spandidos, and K. H. Nicolaides, “First-trimester maternal plasma cell-free fetal DNA and preeclampsia,” American Journal of Obstetrics and Gynecology, vol. 201, no. 5, pp. 472.e1–472.e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. X. Y. Zhong, W. Holzgreve, and S. Hahn, “The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia,” Hypertension in Pregnancy, vol. 21, no. 1, pp. 77–83, 2002. View at Google Scholar · View at Scopus
  88. R. J. Levine, C. Qian, E. S. Leshane et al., “Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia,” American Journal of Obstetrics and Gynecology, vol. 190, no. 3, pp. 707–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. B. G. Zimmermann, D. G. Maddocks, and N. D. Avent, “Quantification of circulatory fetal DNA in the plasma of pregnant women,” Methods in Molecular Biology, vol. 444, pp. 219–229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. D. W. Swinkels, J. B. de Kok, J. C. M. Hendriks, E. Wiegerinck, P. L. M. Zusterzeel, and E. A. P. Steegers, “Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell-free fetal and maternal DNA in maternal plasma and serum,” Clinical Chemistry, vol. 48, no. 4, pp. 650–653, 2002. View at Google Scholar · View at Scopus
  91. A. Farina, A. Sekizawa, M. Iwasaki, R. Matsuoka, K. Ichizuka, and T. Okai, “Total cell-free DNA (β-globin gene) distribution in maternal plasma at the second trimester: a new prospective for preeclampsia screening,” Prenatal Diagnosis, vol. 24, no. 9, pp. 722–726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Sekizawa, A. Farina, K. Koide et al., “β-globin DNA in maternal plasma as a molecular marker of pre-eclampsia,” Prenatal Diagnosis, vol. 24, no. 9, pp. 697–700, 2004. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Grill, C. Rusterholz, R. Zanetti-Dällenbach et al., “Potential markers of preeclampsia—a review,” Reproductive Biology and Endocrinology, vol. 7, article 70, 2009. View at Publisher · View at Google Scholar · View at Scopus